ACRV

Acrivon Therapeutics, Inc. Common Stock ACRV

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ACRV PMVP RLMD VXRT IMUX RPTX TCRX ATYR CBUS BMEA
6M 90.91 % 3.67 % 469.60 % -38.07 % -24.43 % 54.23 % -39.70 % -86.19 % 6.21 % -53.45 %
YTD -59.40 % -26.14 % 790.91 % -48.67 % -43.14 % 65.91 % -69.95 % -81.85 % -47.97 % -63.41 %
1Y -67.96 % -25.66 % 1 008.65 % -37.55 % -46.79 % 50.00 % -68.73 % -76.96 % -58.93 % -70.91 %
3Y -79.91 % -87.14 % 447.44 % -59.46 % -48.67 % -85.20 % -44.73 % -58.98 % -81.88 % -82.93 %
5Y -86.12 % -97.47 % -42.71 % -95.15 % -96.84 % -93.50 % -91.16 % -58.98 % -99.33 % -92.06 %
10Y -86.12 % -96.99 % 54.23 % -98.19 % -99.86 % -92.89 % -91.16 % -58.98 % -99.73 % -92.06 %
From the beginning -86.12 % -96.99 % -66.58 % -99.68 % -99.88 % -92.89 % -91.16 % -58.98 % -99.73 % -92.06 %

Dividend

Vaxart, Inc.